Table 3.
Diagnostic performance for sarcopenia prediction in the evaluation set (%, μ ± σ).
| Models | ACC | SEN | SPE | PPV | NPV | AUC | P-value* | P-value** |
|---|---|---|---|---|---|---|---|---|
| Clinical | 81.54 ± 4.83 | 67.38 ± 11.7 | 85.59 ± 8.96 | 61.84 ± 13.9 | 90.44 ± 2.37 | 79.47 ± 3.27 | ||
| USG | 69.73 ± 5.47 | 67.64 ± 4.56 | 70.32 ± 7.69 | 40.17 ± 4.84 | 88.40 ± 1.59 | 66.83 ± 3.76 | ||
| FLF | 83.55 ± 4.32 | 60.47 ± 10.6 | 90.14 ± 7.65 | 67.96 ± 13.0 | 89.04 ± 2.22 | 77.71 ± 3.88 | < 0.001+ | < 0.001+ |
| SLF-SR | 73.58 ± 4.96 | 68.39 ± 9.57 | 75.07 ± 8.42 | 45.94 ± 9.30 | 89.44 ± 2.00 | 74.70 ± 3.68 | < 0.001+ | < 0.001+ |
| SLF-LSE | 82.53 ± 6.34 | 60.92 ± 12.9 | 88.70 ± 11.3 | 68.83 ± 17.5 | 89.13 ± 2.44 | 78.35 ± 3.93 | < 0.001+ | < 0.001+ |
| SLF-AAC | 79.39 ± 7.62 | 61.78 ± 12.9 | 84.43 ± 13.0 | 62.39 ± 20.0 | 88.85 ± 2.30 | 76.74 ± 3.83 | < 0.001+ | < 0.001+ |
| SLF-RF | 77.53 ± 7.09 | 62.37 ± 12.4 | 81.86 ± 11.3 | 54.49 ± 15.1 | 88.64 ± 2.68 | 71.16 ± 5.63 | < 0.001+ | < 0.001+ |
| SLF-SVM | 80.20 ± 6.23 | 56.83 ± 14.1 | 86.87 ± 10.7 | 61.32 ± 15.4 | 87.89 ± 2.98 | 69.92 ± 7.84 | < 0.001+ | < 0.001+ |
| SLF-AB | 83.17 ± 5.51 | 59.97 ± 9.83 | 89.80 ± 8.80 | 67.47 ± 14.2 | 88.57 ± 5.14 | 74.78 ± 4.39 | < 0.001+ | < 0.001+ |
*μ = mean, σ = standard deviation, ACC = accuracy, SEN = sensitivity, SPE = specificity, PPV = positive predictive value, NPV = negative predictive value, and AUC = area under the receiver operating characteristics (ROC) curve, FLF = feature-level fusion, SLF-SR = score-level fusion by the sum-rule, SLF-LSE = score-level fusion by the least squares estimation, SLF-AAC = score-level fusion by area above the ROC curve optimization, SLF-RF = score-level fusion by random forest, SLF-SVM = score-level fusion by support vector machine, SLF-AB = score-level fusion by AdaBoost.
* Comparison of accuracy between the clinical features and after fusion (paired t-test).
** Comparison of accuracy between the USG features and after fusion (paired t-test).
+ Statistically significant.